Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany.

Rexroth, Ute; Hamouda, Osamah; Hanefeld, Johanna; Ruehe, Bettina; Wieler, Lothar H; Schaade, Lars

Rexroth, Ute; Hamouda, Osamah; Hanefeld, Johanna; Ruehe, Bettina; Wieler, Lothar H; Schaade, Lars.

Rexroth U; Robert Koch Institute, Berlin, Germany.
Hamouda O; Robert Koch Institute, Berlin, Germany.
Hanefeld J; Robert Koch Institute, Berlin, Germany.
Ruehe B; Robert Koch Institute, Berlin, Germany.
Wieler LH; Robert Koch Institute, Berlin, Germany.
Schaade L; Robert Koch Institute, Berlin, Germany.

Euro Surveill ; 25(23)2020 06.

Article in English | MEDLINE | ID: covidwho-594582

Subject(s)

Pandemics; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; COVID-19; Coronavirus Infections; Disease Outbreaks; Germany; Humans; Pneumonia, Viral; SARS-CoV-2; Tertiary Care Centers

Keywords

COVID-19; SARS-CoV-2; international risk areas; pandemic; testing strategy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / Pandemics Type of study: Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.ES.2020.25.23.2001119

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google